Phosphatidylserine expressing platelet microparticle levels at hospital presentation are decreased in sepsis non-survivors and correlate with thrombocytopenia

Thrombosis Research

Volumn 168, Issue , 2018, Pages 138-144

  Puskarich, Michael A ^a   Cornelius, Denise C ^b   Bandyopadhyay, Sibali ^b   McCalmon, Maggie ^b   Tramel, Robert ^b   Dale, Wood D ^b   Jones, Alan E ^b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; FIBRINOGEN RECEPTOR; LACTIC ACID; PHOSPHATIDYLSERINE;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; EMERGENCY WARD; FEMALE; HOSPITAL MORTALITY; HUMAN; INTENSIVE CARE UNIT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PLATELET COUNT; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SEPSIS; STANDARDIZED INCIDENCE RATIO; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTOPENIA; BLOOD; DRUG EFFECT; METABOLISM; THROMBOCYTE;

BLOOD PLATELETS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHATIDYLSERINES; SEPSIS; THROMBOCYTOPENIA;

EID: 85049334557     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2018.06.017     Document Type: Article

References (24)

1. Torio, C.M., Moore, B.J., National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013: Statistical Brief #204. 2006 February.
2. Gaieski, D., Edwards, J., Kallan, M., Carr, B., Benchmarking the incidence and mortality of severe sepsis in the United States. Crit. Care Med. 41:5 (2013), 1167–1174 (Ref Type: Generic).
3. Rossaint, J., Zarbock, A., Pathogenesis of Multiple Organ Failure in Sepsis. Crit. Rev. Immunol. 35:4 (2015), 227–291.
4. Shankar-Hari, M., Phillips, G.S., Levy, M.L., Seymour, C.W., Liu, V.X., Deutschman, C.S. et al., Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:8 (2016 February 23), 775–787.
5. Seymour, C.W., Liu, V.X., Iwashyna, T.J., Brunkhorst, F.M., Rea, T.D., Scherag, A. et al., Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:8 (2016 February 23), 762–774.
6. Sharma, B., Sharma, M., Majumder, M., Steier, W., Sangal, A., Kalawar, M., Thrombocytopenia in septic shock patients - a prospective observational study of incidence, risk factors and correlation with clinical outcome. Anaesth. Intensive Care 35:6 (2007), 874–880 (Ref Type: Generic).
7. Moreno, R., Vincent, J.L., Matos, R., Mendonca, A., Cantraine, F., Thijs, L. et al., The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working group on sepsis related problems of the ESICM. Intensive Care Med. 25:7 (1999 July), 686–696.
8. Levi, M., Cate, H.T., Disseminated intravascular coagulation. N. Engl. J. Med. 341 (1999), 586–592 (Ref Type: Generic).
9. De Backer, D., Donadello, K., Sakr, Y., Ospina-Tascon, G., Salgado, D., Scolletta, S. et al., Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome. Crit. Care Med. 41:3 (2013), 791–799 (Ref Type: Generic).
10. Oh, D., Jang, M.J., Lee, S.J., Chong, S.Y., Kang, M.S., Wada, H., Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis. Thromb. Res. 126:1 (2010), 18–23 (Ref Type: Generic).
11. Delabranche, X., Quenot, J.P., Lavigne, T., Mercier, E., Francois, B., Severac, F. et al., Early detection of disseminated intravascular coagulation during septic shock: a multicenter prospective study. Crit. Care Med. 44:10 (2016 October), e930–e939.
12. Morel, O., Jesel, L., Freyssinet, J.M., Toti, F., Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler. Thromb. Vasc. Biol. 31:1 (2011 January), 15–26.
13. Ogura, H., Kawasaki, T., Tanaka, H., Koh, T., Tanaka, R., Ozeki, Y. et al., Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J. Trauma 50:5 (2001 May), 801–809.
14. Zhang, Y., Meng, H., Ma, R., He, Z., Wu, X., Cao, M. et al., Circulating microparticles, blood cells, and endothelium induce procoagulant activity in sepsis through phosphatidylserine exposure. Shock 45:3 (2016 March), 299–307.
15. Wang, Y., Zhang, S., Luo, L., Norstrom, E., Braun, O.O., Morgelin, M. et al., Platelet-derived microparticles regulates thrombin generation via phophatidylserine in abdominal sepsis. J. Cell. Physiol. 233:2 (2018 February), 1051–1060.
16. Lehner, G.F., Harler, U., Haller, V.M., Feistritzer, C., Hasslacher, J., Dunzendorfer, S. et al., Characterization of microvesicles in septic shock using high-sensitivity flow cytometry. Shock 46:4 (2016 October), 373–381.
17. Tokes-Fuzesi, M., Woth, G., Ernyey, B., Vermes, I., Muhl, D., Bogar, L. et al., Microparticles and acute renal dysfunction in septic patients. J. Crit. Care 28:2 (2013 April), 141–147.
18. Mostefai, H.A., Meziani, F., Mastronardi, M.L., Agouni, A., Heymes, C., Sargentini, C. et al., Circulating microparticles from patients with septic shock exert protective role in vascular function. Am. J. Respir. Crit. Care Med. 178:11 (2008 December 1), 1148–1155.
19. Shaver, C.M., Woods, J., Clune, J.K., Grove, B.S., Wickersham, N.E., McNeil, J.B. et al., Circulating microparticle levels are reduced in patients with ARDS. Crit. Care, 21(1), 2017 May 25, 120.
20. Soriano, A.O., Jy, W., Chirinos, J.A., Valdivia, M.A., Velasquez, H.S., Jimenez, J.J. et al., Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Crit. Care Med. 33:11 (2005 November), 2540–2546.
21. Jones, A.E., Shapiro, N., Trzeciak, S., Arnold, H., Claremont, H., Kline, J.A., Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 303:8 (2010), 739–746 (Ref Type: Generic).
22. Jones, A., Shapiro, N., Trzeciak, S., Arnold, R., Kline, J., Multi-center randomized controlled trial of lactate clearance versus central venous oxygen saturation as the endpoint of early sepsis resuscitation. Acad. Emerg. Med., 16(4 Suppl 1), 2009, S143 (Ref Type: Abstract).
23. Boilard, E., Duchez, A.C., Brisson, A., The diversity of platelet microparticles. Curr. Opin. Hematol. 22:5 (2015 September), 437–444.
24. Chandrashekar, V., DIC score: statistical relationship with PT, APTT, and simplified scoring systems with combinations of PT and APTT. ISRN Hematol., 2012, 2012, 579420.